Vijaya Diagnostic Centre Limited — PPTs, 28-07-2025: Investor Presentation

Here's a summary tailored to your preferences:

**Financial Highlights:**

Q1 FY26 revenue grew 20.4% YoY to **₹188.1 Cr**. EBITDA stood at **₹73.5 Cr** (39.1% margin), and PAT **₹38.3 Cr** (20.4% margin). The Hyderabad market saw double-digit growth. Operational performance was strong, with **11 lakh** footfalls, **39.4 lakh** tests, and 93% B2C revenue.

**Strategic Initiatives & Growth Drivers:**

New hubs in Pune, Bengaluru, and West Bengal are operational, with the Nizamabad hub achieving quick break-even. Three additional hubs are planned for Q2 FY26, and two more by H2 FY26, reinforcing the company's hub-and-spoke expansion strategy.

**Business Developments:**

Vijaya Diagnostic acquired P.H. Diagnostics in Pune, integrating new centers under the Vijaya PH Brand. Two hubs were also launched in Bengaluru, strategically entering this key market.

**Market Position & Competitive Advantage:**

As India's largest integrated B2C diagnostic chain, Vijaya dominates Telangana and AP. Its integrated services, advanced equipment, and robust IT infrastructure provide a competitive edge, supporting high B2C concentration and strong margins.

**Investor Implications:**

Robust Q1 financials, coupled with effective strategic expansions and rapid break-even for new centers, signal positive growth potential. Continued geographic diversification and a proven operational model suggest sustained revenue and margin stability.